Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported $43.26M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Actinium Pharmaceuticals USD 43.26M 6.12M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 322.94M 221.99M Dec/2025
Pfizer USD 42.82B 76M Mar/2026